Shanghai Serum Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000059X8
CNY
47.68
3.37 (7.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
195.40
194.14
189.37
173.55
207.97
184.97
188.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
195.40
194.14
189.37
173.55
207.97
184.97
188.10
Raw Material Cost
50.98
50.31
51.53
32.79
37.91
33.77
27.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
55.29
53.19
52.64
41.69
40.30
30.53
32.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.20
0.46
0.69
0.69
0.73
0.02
0.02
Selling and Distribution Expenses
73.33
73.07
71.84
69.64
60.82
48.40
57.74
Other Expenses
-3.96
-3.32
-2.64
-2.99
-1.74
-0.96
-1.48
Total Expenditure (Excl Depreciation)
140.18
143.80
150.31
114.88
122.34
103.09
103.43
Operating Profit (PBDIT) excl Other Income
55.199999999999996
50.300000000000004
39.1
58.7
85.60000000000001
81.89999999999999
84.7
Other Income
11.00
20.12
17.86
23.66
9.41
9.84
5.33
Operating Profit (PBDIT)
82.52
86.75
68.27
89.66
106.43
96.72
94.58
Interest
0.20
0.46
0.69
0.69
0.73
0.02
0.02
Exceptional Items
1.41
-4.97
2.59
2.66
0.15
0.00
0.12
Gross Profit (PBDT)
144.42
143.83
137.84
140.76
170.07
151.20
160.45
Depreciation
19.53
20.34
17.40
15.14
15.28
12.75
10.93
Profit Before Tax
64.21
60.98
52.77
76.50
90.58
83.95
83.75
Tax
12.42
6.28
6.64
9.84
11.39
11.58
12.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.79
44.29
38.77
64.20
76.48
63.17
65.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.79
44.29
38.77
64.20
76.48
63.17
65.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.79
44.29
38.77
64.20
76.48
63.17
65.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,112.66
1,095.50
1,085.84
1,121.63
369.63
293.15
336.94
Earnings per share (EPS)
0.48
0.41
0.36
0.59
0.71
0.58
0.61
Diluted Earnings per share
0.48
0.41
0.36
0.59
0.71
0.58
0.61
Operating Profit Margin (Excl OI)
26.61%
23.84%
17.43%
29.31%
39.3%
40.08%
41.64%
Gross Profit Margin
42.85%
41.89%
37.05%
52.8%
50.9%
52.28%
50.34%
PAT Margin
26.5%
22.81%
20.47%
36.99%
36.78%
34.15%
34.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 0.67% vs 2.48% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 16.93% vs 14.18% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 7.36% vs 32.14% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -60.00% vs -28.57% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Shanghai Serum Bio-Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
195.40
0
195.40
Other Operating Income
0.00
0.00
0.00
Total Operating income
195.40
0
195.40
Raw Material Cost
50.98
0
50.98
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
55.29
0
55.29
Power Cost
0
0
0.00
Manufacturing Expenses
0.20
0
0.20
Selling and Distribution Expenses
73.33
0
73.33
Other Expenses
-3.96
0.00
-3.96
Total Expenditure (Excl Depreciation)
140.18
0
140.18
Operating Profit (PBDIT) excl Other Income
55.22
0.00
55.22
Other Income
11.00
0
11.00
Operating Profit (PBDIT)
82.52
0
82.52
Interest
0.20
0
0.20
Exceptional Items
1.41
0
1.41
Gross Profit (PBDT)
144.42
0
144.42
Depreciation
19.53
0
19.53
Profit Before Tax
64.21
0
64.21
Tax
12.42
0
12.42
Provisions and contingencies
0
0
0.00
Profit After Tax
51.79
0
51.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.79
0
51.79
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.79
0
51.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,112.66
0
1,112.66
Earnings per share (EPS)
0.48
0
0.48
Diluted Earnings per share
0.48
0
0.48
Operating Profit Margin (Excl OI)
26.61%
0%
0.00
26.61%
Gross Profit Margin
42.85%
0%
0.00
42.85%
PAT Margin
26.50%
0%
0.00
26.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 19.54 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.67% vs 2.48% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 5.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 16.93% vs 14.18% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.15 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.36% vs 32.14% in Dec 2024

Annual - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -60.00% vs -28.57% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.61%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024